Showing results (701-710 of 1,238) with videos related to
Sort By:
Pageof 124
Cancer Treatment and Research Communications|April 27, 2021
RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysisS Ponce Aix, S Novello, E B Garon, et al.Cancer Treatment and Research Communications|April 24, 2023
Identification of circulating tumour DNA (ctDNA) from the liquid biopsy results: Findings from an observational cohort studyKhin Zay Yar Myint, Masamori Shimabuku, Ruriko Horio, et al.Cancer Treatment and Research Communications|April 17, 2021
Complex renal cysts combined with hemorrhage during crizotinib treatment for ALK-rearranged lung adenocarcinomaLing Yang, Jianing Gu, Xiaomin NiuCancer Treatment and Research Communications|April 10, 2021
Learning curve in robotic-assisted lobectomy for non-small cell lung cancer is not steep after experience in video-assisted lobectomy; single-surgeon experience using cumulative sum analysisSaana E-M Andersson, Ilkka K Ilonen, Otto H Pälli, et al.Cancer Treatment and Research Communications|September 29, 2022
The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinomaAndrew W Hahn, Justin Lebenthal, Giannicola Genovese, et al.Cancer Treatment and Research Communications|November 3, 2022
The miR-17-92 cluster: Yin and Yang in human cancersWenyuan Zhao, Ananya Gupta, Janusz Krawczyk, et al.Cancer Treatment and Research Communications|November 21, 2023
Molecular characterization of plasmacytoid urothelial carcinoma and the impact on treatment implicationsKristin Weiss, Kathryn H Gessner, Alysen Demzik, et al.Cancer Treatment and Research Communications|January 7, 2024
Pregnancy-related breast cancer: 14-year experience in a tertiary institution in Hong KongBilly Ho Hung Cheung, Vivian Chi Mei Man, Goby Tze Wa Sham, et al.Cancer Treatment and Research Communications|January 8, 2024
EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort studyÅslaug Helland, Tor Åge Myklebust, Simona Conte, et al.Cancer Treatment and Research Communications|December 27, 2023
Programmed death ligand-1 (PD-L1) clone 22C3 expression in resected colorectal cancer as companion diagnostics for immune checkpoint inhibitor therapy: A comparison study and inter-rater agreement evaluation across proposed cut-offs and predictive (TPS, CPS and IC) scoresDordi Lea, Claudia Zaharia, Kjetil SøreidePageof 124